These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Determination of a new antiulcer agent, YJA-20379-1 in plasma, urine, blood, and tissue homogenates by high-performance liquid chromatography.
    Author: Kim SH, Choi WS, Chang MS, Lee MG.
    Journal: Res Commun Mol Pathol Pharmacol; 1997 Jul; 97(1):107-12. PubMed ID: 9507573.
    Abstract:
    A high-performance liquid chromatographic method was developed for the determination of a new antiulcer agent, YJA-20379-1, in human plasma and urine, and rat blood and tissue homogenates. The sample preparation was simple: a 2.5-volume of acetonitrile was added to the biological sample to deproteinize it. A 50-microliter aliquot of the supernatant was injected onto a C18 reversed-phase column. The mobile phase employed was methanol--0.1 M Sørensen phosphate buffer of pH7.0--H2O (80:2:15, v/v/v), and was run at a flow-rate of 0.7 ml/min. The column effluent was monitored by ultraviolet detector at 254 nm. The retention time for YJA-20379-1 was approximately 6.3 min. The detection limits for YJA-20379-1 in human plasma and urine, and rat tissue homogenate (including blood) were 50, 100, and 100 ng/ml, respectively. The coefficients of variation of the assay (within-day and between-day) were generally low (below 9.44%) for the human plasma and urine, and rat blood and tissue homogenate. No interference from endogenous substances were found.
    [Abstract] [Full Text] [Related] [New Search]